[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.120.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 343
Citations 0
Review
September 2016

Recruiting Patients With Stroke Into Cell Therapy TrialsA Review

Author Affiliations
  • 1Department of Neurology, The University of Texas Health Science Center at San Antonio
  • 2Department of Neurology, The University of Texas Health Science Center at Houston
JAMA Neurol. 2016;73(9):1141-1144. doi:10.1001/jamaneurol.2016.0940
Abstract

Importance  Clinical trials are under way to test the safety and efficacy of different types of cell therapies in patients with ischemic stroke. The informed consent process for recruitment of patients with stroke in cell therapy trials is complex and requires extensive discussions on multiple aspects.

Observations  Various issues in approaching patients with stroke and their families and discussing participation in cell therapy studies are described, including participation in clinical trials, clarifying the perception of stem cell therapy and the risks of bone marrow harvest, and discussing risks vs benefits, cell-based therapies for chronic stroke, and consent for minority and immigrant populations.

Conclusions and Relevance  Informed consent for cell therapy studies in patients with stroke requires lengthy discussions about several issues unique to clinical trials in stroke patients. Careful thought is needed to create an informative consent process.

×